Document is current
Any future updates will be listed below
-
Authors
Suda, Goki
Baba, Masaru
Yamamoto, Yoshiya
Yoshida, Sonoe
Muranaka, Tetsuhito
Meguro, Takashi
Terashita, Katsumi
Ito, Jun
Kobayashi, Tomoe
Izumi, Takaaki
Takagi, Tomofumi
Hosoda, Shunichi
Yamada, Ren
Fu, Qingjie
Yang, Zijian
Yokoyama, Daisuke
Tanaka, Takatsugu
Meno, Akimitsu
Yasuura, Naohiro
Kitagataya, Takashi
Ohara, Masatsugu
Kawagishi, Naoki
Nakai, Masato
Sho, Takuya
Ogawa, Koji
Sakamoto, Naoya
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP25fk0210126, JP25fk0310545, JP24fk0210121, JP25fk0210142, JP25fk0310551, JP25fk0210123, JP25fk0310535, JP25fk0210157, JP25fk0310543, JP25fk0210172 JP25fk0210174, JP25fk0210143)
Gilead Research Scholars
- License Information
-
More Information
Article History
Received: 19 September 2025
Accepted: 30 October 2025
First Online: 28 November 2025
Declarations
:
: Professor Naoya Sakamoto received lecture fees from Chugai Pharmaceutical Co., Ltd, Gilead Sciences, Inc. and AbbVie Inc, grants and endowments from MSD K.K and Chugai Pharmaceutical Co., Ltd, and a research grant from AbbVie Inc. Dr. Goki Suda received research grants from Gilead Sciences. The other authors have no conflicts of interest to disclose.
